CG Oncology, Inc. Common stock
CGON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$88 | -$49 | -$35 | -$13 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $2 | $1 | $1 |
| Change in WC | $3 | $3 | $4 | -$2 |
| Other Non-Cash | -$5 | -$2 | $1 | $0 |
| Operating Cash Flow | -$79 | -$46 | -$30 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,046 | -$518 | -$55 | $0 |
| Inv. Sales/Matur. | $745 | $396 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$301 | -$121 | -$55 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$16 | $0 | $15 |
| Stock Issued | $629 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $103 | $120 | $0 |
| Financing Cash Flow | $628 | $87 | $120 | $15 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $249 | -$80 | $35 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8 | $88 | $54 | $52 |
| End Cash | $257 | $8 | $88 | $54 |
| Free Cash Flow | -$79 | -$46 | -$30 | -$14 |